LFMD (LifeMD) Other Financing: $6.5 Mil (TTM As of Mar. 2026)


LFMD LifeMD Inc LFMD
76 GF Score
Price $4.33
GF Value $5.71
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is LifeMD Other Financing?

LifeMD LFMD +4.97% 76 Other Financing is $6.5 Mil as of Mar. 2026. GuruFocus rates LFMD with a GF Score™ of 76/100 and a GF Value™ of $5.71 (Modestly Undervalued). The stock has 3 warning signs investors should review.

LifeMD's Other Financing for the three months ended in Mar. 2026 was $0.1 Mil.

LifeMD's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was $6.5 Mil.

LifeMD Other Financing Historical Data

* Premium members only.

The historical data trend for LifeMD's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeMD Other Financing Chart

LifeMD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.71 -0.16 -0.67 -0.69 -0.30

LifeMD Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -2.33 8.74 -0.01 0.08
LFMD
76GF Score
LifeMD Inc LFMD
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LifeMD Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $6.5 Mil mean?
LifeMD (LFMD) has a Other Financing of $6.5 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for LifeMD and its competitors.
Is LifeMD's Other Financing too high?
LifeMD's current Other Financing is $6.5 Mil. Overall, LifeMD has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LifeMD's Other Financing compare to SPOK and AMWL?
LifeMD's Other Financing of $6.5 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for LifeMD and its competitors. LifeMD's current Other Financing is $6.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeMD stock overvalued right now?
Based on GuruFocus' analysis, LifeMD (LFMD) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.71, compared to a current price of $4.33 — trading 24.2% below its estimated fair value. The current Other Financing is $6.5 Mil. LifeMD's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For LifeMD (LFMD), the current Other Financing is $6.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LifeMD (LFMD) Overvalued in 2026?

Based on GuruFocus' analysis, LifeMD stock appears to be undervalued. The current stock price of $4.33 is trading 24.2% below its estimated GF Value™ of $5.71. GuruFocus considers LifeMD to be Modestly Undervalued.

Key valuation signals for LFMD:

  • Other Financing: $6.5 Mil
  • GF Value™: $5.71 vs. price of $4.33 (24.2% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the LFMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LifeMD Business Description

Address 236 Fifth Avenue, Suite 400, New York, NY, USA, 10001
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
76GF Score

Get the complete analysis for LFMD

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.33
Price
$5.71
GF Value